North American Pediatric Allergy and Asthma Congress 2024
Price: $595 for ACAAI/CSACI members, $795 non-members, $225 students/residents/FITs, $795 non-exhibiting industry attendees
To access handouts, make sure you are logged in and click on the TAKE COURSE button. Handouts are contained within the course.
REFUNDS/CANCELLATIONS
Refunds, cancellations, and changes are available (minus $75 administration fee) if your request is received via email (education@acaai.org) on or before March 31, 2024. Cancellation requests received after March 31, 2024 are not eligible for a refund.
**CSACI members only - use coupon code CSACI24 during checkout for discounted price**
Don’t miss this exciting opportunity to be part of the 2nd North American Pediatric Allergy and Asthma Congress (NAPAAC) that will take place April 12-14, 2024, at the JW Marriott Las Vegas Resort & Spa. This 3-day CME program – developed jointly by the American College of Allergy, Asthma and Immunology (ACAAI) and the Canadian Society of Allergy and Clinical Immunology (CSACI) – will focus entirely on pediatric allergies and related conditions.
NAPAAC aims to deliver state of the art evidence-based practical approaches to assist diagnosis and management of common pediatric conditions. Sessions are designed to be engaging, interactive, and entertaining. Attendees will not only learn pearls to apply immediately into clinical practice, but will hear experts in the specialty of allergy/immunology offer insight and perspective regarding new paradigms of care.
Join us for NAPAAC 2024: Advances in Pediatric Allergy: Moving Towards Proactive Management
Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 15.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 15.75 contact hours.
Royal College of Physicians
Under its agreement with the ACCME, the Royal College of Physicians and Surgeons of Canada will recognize the number of participation hours at NAPAAC as MOC Program Section 1 accredited group learning credits.
Commercial Support
This activity is supported in party by independent medical educational (IME) grants from Takeda
Target Audience
Allergists, pediatricians, family physicians and other allergy healthcare providers.
Learning Objectives
At the conclusion of this activity learners should be able to…
1. Translate new evidence regarding treatment of allergic conditions into clinical practice
2. Incorporate shared decision making with patients surrounding various management options
3. Utilize an individualized approach for patients with food allergy, allergic rhinitis and asthma
4. Increase awareness surrounding paradigm shifts in prevention, diagnosis and management
NAPAAC 2024 PROGRAM | ||
FRIDAY APRIL 12 | ||
11:00 am - 5:30 pm | Registration | |
1:00 pm - 1:15 pm | Welcome/Introductions | David Stukus, MD, Douglas Mack, MD, MSc |
1:15 pm - 2:00 pm | Keynote Presentation In This Age of Misinformation, Evidence-Based Communication is Key (More, Please) | Timothy Caulfield, BSc, LL.B, LL.M |
2:00 pm - 2:30 pm | Let the Babies Eat: Instilling Confidence Surrounding Early Introduction of Allergenic Foods | Mimi Tang, MBBS, PhD |
2:30 pm - 3:00 pm | Prognosis from an Early Age: How to use Phenotyping to Guide Management of Asthma, Atopic Dermatitis, and Food Allergy | David Stukus, MD |
3:00 pm - 3:15 pm | Q & A | Douglas Mack, MD, MSc, David Stukus, MD |
3:15 pm - 3:30 pm | Break | |
3:30 pm - 4:00 pm | Pro/Con: Penicillin Allergy Delabeling Should be Done in Primary Care Offices | Maureen Petersen, MD, Moshe Ben-Shoshan, MD, MSc |
4:00 pm - 4:30 pm | Lessons Learned From the COVID-19 Pandemic: Why We Can’t Go Back to the Way Things Were | Victoria Cook, MSc, MD |
4:30 pm - 5:30 pm | Happy Hour/Fireside Chat with Dave and Friends | David Stukus, MD |
5:45 pm - 7:15 pm | NonCME Industry Forum Dinner | |
SATURDAY APRIL 13 | ||
6:45 am - 5:00 pm | Registration | |
7:00 am - 7:45 am | Breakfast Symposium New Paradigms in the Management of Anaphylaxis | Jay Lieberman, MD |
7:45 am - 8:30 am | Keynote Presentation If You're Not Using Shared Decision Making for Atopic Conditions, then You're Doing it All Wrong | Matthew Greenhawt, MD, MBA, MSc |
8:30 am- 9:00 am | Managing Asthma in Children: When to Step Up and When to Step Down | William Anderson, MD |
9:00 am - 9:15 am | Q & A | Douglas Mack, MD, MSc, David Stukus, MD |
9:15 am - 9:45 am | Break/Visit Exhibit Hall | |
9:45 am - 10:15 am | Why Everything You Thought You Knew About Atopic Dermatitis is Outdated | Vikash Oza, MD |
10:15 am - 10:45 am | The Most Practical Talk About Diagnosing Food Allergy That You’ve Ever Heard (AKA: Why panel food testing really hurts) | Mariam Hanna, MD |
10:45 am - 11:15 am | Saturday Symposium - sponsored by an independent education grant from Takeda. Who, When, Why and How to Start an Evaluation for Primary Immune Deficiency | Ben Prince, MD, MSCI |
11:15 am - 11:45 am | Pro/Con: Baked Food Ingestion Hastens the Resolution of Food Allergy | Anna Nowak-Wegrzyn, MD, PhD Mimi Tang, MBBS, PhD |
11:45 am - 12:00 pm | Fido’s Gotta Go: Top 10 Practical Tips for Managing Allergic Rhinoconjunctivitis in Children | Syed Shahzad Mustafa, MD |
12:00 pm - 12:10 pm | Q & A | David Stukus, MD, Douglas Mack, MD, MSc |
12:10 pm - 1:00 pm | Lunch in Exhibit Hall | |
1:00 pm - 1:45 pm | Selecting the Best Biologic for Your Patient | Shahzad Mustafa, MD |
1:45 pm - 2:45 pm | Breakout Session 1A Challenging Cases: Diagnostic Dilemmas | |
1:45 pm - 2:45 pm | Breakout Session 2A Challenging Cases: Management Dilemmas | |
1:45 pm - 2:45 pm | Breakout Session 3A Challenging Cases: Dr. Google, Nonadherence, and Resistance to Change | |
2:45 pm - 3:15 pm | Break in Exhibit Hall / Change Breakouts | |
3:15 pm - 4:15 pm | Breakout Session 1B Challenging Cases: Diagnostic Dilemmas | |
3:15 pm - 4:15 pm | Breakout Session 2B Challenging Cases: Management Dilemmas | |
3:15 pm - 4:15 pm | Breakout Session 3B Challenging Cases: Dr. Google, Nonadherence, and Resistance to Change | |
4:20 pm - 5:00 pm | Stump the Expert with Doug and Friends | Douglas Mack, MD, MSc |
5:00 pm - 6:00 pm | NAPAAC Reception Social Hour in the Exhibit Hall | |
6:15 pm - 7:45 pm | NonCME Industry Forum Dinner | |
SUNDAY APRIL 14 | ||
6:45 am - 12:30 pm | Registration | |
7:00 am - 8:00 am | Breakfast Symposium - sponsored by an independent education grant from Takeda. How to Use Shared Decision Making to Guide Management of Eosinophilic Esophagitis | Natacha Tardio, MD |
8:00 am - 8:30 am | Changing the course of allergic rhinitis – a focus on sublingual immunotherapy | Douglas Mack, MD, MSc |
8:30 am - 9:00 am | Pro/Con: Mast Cell Activation Syndrome is More Common Than We Think | Moshe Ben-Shoshan, MD, MSc, Matthew Greenhawt, MD, MBA, MSc |
9:15 am - 9:30 am | Q&A | David Stukus, MD, Douglas Mack, MD, MSc |
9:30 am - 10:00 am | Break/Visit Exhibit Hall | |
10:00 am - 10:30 am | It’s Time to Rethink Our Use of First Generation Antihistamines | Elissa Abrams, MD, MPH |
10:30 am - 11:00 am | Food Oral Immunotherapy: Risks, Benefits, and Expected Outcomes | Mimi Tang, MBBS, PhD |
11:00 am - 11:30 am | Transitioning Adolescents with Allergic Conditions Towards Independence | William Anderson, MD |
11:30 pm - 12:00 pm | The Best Mandatory Wellness Talk You’ll Ever Get | David Stukus, MD |
12:00 pm - 12:15 pm | Q & A | Douglas Mack, MD, MSc |
12:15 pm - 12:30 pm | Closing Remarks | David Stukus, MD, Douglas Mack, MD, MSc |
Hotel Room Rate & Resort Fee: $219 Single / Double + 13% tax and a reduced Resort Fee of $40 / night - ROOM BLOCK IS SOLD OUT
Reserve by Phone: 1-877-622-3140 or 1-800-582-2996
Planners, Faculty & Disclosures
All identified relevant financials relationships with ineligible companies have been mitigated.
Elissa Abrams, MD: Planner, Speaker - no relevant financial relationships with ineligible companies to disclose
William Anderson, MD: Speaker - Advisor: Genentech, Regeneron, Sanofi
Moshe Ben-Shosham, MD, MSc: Planner, Speaker - Speaker: Novartis, Stallergenes Greer, Sanofi, Medexsus
Timothy Caulfield, LLM, JD, BSc: Speaker - no relevant financial relationships with ineligible companies to disclose
Victoria Cook, MSc, MD: Planner, Speaker - Speaker: Aralez Pharma, Pfizer
Matt Greenhawt, MD, MBA, MSc: Speaker - Advisor: Alk-Abello, DBV Technologies, Genentech, Novartis; Researcher: DBV Technologies, Novartis
Mariam Hanna, MD: Planner, Speaker - Advisor: ALK, Trudell; Speaker: ALK, Covis, Trudell, Medexus, Pfizer, Researcher: ALKDBV, AstraZeneca; Consultant: ALK
Jay Lieberman, MD: Speaker - Researcher: DBV Technologies, Novartis
Douglas Mack, MD, MSc: Co-Chair, Planner, Speaker - Researcher: DBV, AstraZeneca, Dermavent, Arcutis, ALK; Speaker: Bausch, Covis, Medexus; Investigator: ALK
Syed Shahzad Mustafa, MD: Speaker - Speaker: Genentech, AstraZeneca, GlaxoSmithKline, Regeneron; Advisor: AstraZeneca
Anna Nowak-Wegrzyn, MD, PhD: Planner, Speaker - Advisor: Nestle; Speaker: Nutricia; Researcher: Nutricia, DBV; Consultant: Nestle, Labcorp
Vikash Oza, MD: Speaker - Consultant: Dermavant; Advisor: Cerave; Researcher: Pfizer
Purvi Parikh, MD: Planner - Advisor: Takeda; Speaker: Takeda
Maureen Petersen, MD: Planner, Speaker - no relevant financial relationships with ineligible companies to disclose
Benjamin T. Prince, MD, MSc: Planner, Speaker - no relevant financial relationships with ineligible companies to disclose
David Stukus, MD, FACAAI: Co-Chair, Planner, Speaker - Researcher: DBV Technologies; Consultant: Novartis, ARS Pharmaceuticals
Mimi Tang, MBBS, PhD: Speaker - Consultant: Proto Therapeutics
Natacha Tardio, MD: Speaker - Speaker: Sanofi, AVIR, Medexus, Amgen, AstraZeneca; Consulting: Sanofi
Staff Disclosures
Jasmin Lidington, CAE: Planner - no relevant financial relationships with ineligible companies to disclose
Mary Carol Badat, MAdEd: Planner - no relevant financial relationships with ineligible companies to disclose
Available Credit
- 15.75 AMA PRA Category 1 Credit™
- 15.75 Attendance
- 15.75 CBRN
EXHIBITORS & INDUSTRY PARTNERS
Don’t miss this exciting opportunity to be part of the 2nd North American Pediatric Allergy and Asthma Congress (NAPAAC) that will take place April 12-14, 2024, at the JW Marriott Las Vegas Resort & Spa. This 3-day CME program – developed jointly by the American College of Allergy, Asthma and Immunology (ACAAI) and the Canadian Society of Allergy and Clinical Immunology (CSACI) – will focus entirely on pediatric allergies and related conditions, with cutting-edge, interactive presentations.
Plan now to join the list of exhibitors at NAPAAC 2024: Advances in Pediatric Allergy: Moving Towards Proactive Management. A wide variety of sponsorship opportunities are also available.
Download the EXHIBITOR & SPONSORSHIP PROSPECTUS
Aquestive Therapeutics, Inc. Booth 16
Contact Name: Stephanie Varjan
Contact Email: info@aquestive.com
Website: https://aquestive.com
ARS Pharma Booth 8
Contact Name: Bessie Souder
Contact Email: bessies@ars-pharma.com
Website: https://ars-pharma.com
AstraZeneca Booth 7
Contact Name: Pamela Tsuzaki
Contact Email: pamela.tsuzaki@astrazeneca.com
Website: https://www.astrazeneca-us.com/
BioCryst Booth 11
Contact Name: Oleg Chovkovy
Contact Email: ochovkovy@biocryst.com
Website: https://www.biocryst.com/
DBV Technologies Booth 4
Contact Name: Jeff Germani
Contact Email: jeff.germani@dbv-technologies.com
Website: https://dbv-technologies.com
FAACT Booth 12
Contact Name: Eleanor Garrow
Contact Email: eleanor.garrow@foodallergyawareness.org
Website: https://www.foodallergyawareness.org
Genentech Booth 2 & 3
Contact Name: Emily Beck
Contact Email: beck.emily@gene.com
Website: www.gene.com
HollisterStier Booth 18
Contact Name: Rani Duffey
Contact Email: rania.duffey@jubl.com
Website: www.hsallergy.com
Incyte Dermatology Booth 10
Contact Name: Matt Royle
Contact Email: mroyle@incyte.com
Website: https://incyte.com/
Lincoln Diagnostics Booth 6
Contact Name: John Lenski
Contact Email: jlenski@lincolndiagnostics.com
Website: www.lincolndiagnostics.com
NeilMed Booth 17
Contact Name: Ashly Guntz
Contact Email: ashly.guntz@neilmed.com
Website: www.neilmed.com
Nutricia Booth 5
Contact Name: Carolyn Ricciardi
Contact Email: carolyn.ricciardi@danone.com
Website: www.nutricia-na.com/
Octapharma USA, Inc. Booth 15
Contact Name: Holly Ogilvie
Contact Email: holly.ogilvie@octapharma.com
Website: www.octapharmausa.com
Pharming Booth 14
Contact Name: Kristie Cline
Contact Email: k.cline@pharming.com
Website: www.pharming.com
Sanofi Regeneron Booth 19
Contact Name: Jamie Goddard
Contact Email: James.goddard@regeneron.com
SmartPractice Booth 1
Contact Name: Rachel Haferman
Contact Email: dermmarketing@smartpractice.com
Website: smartpractice.com/derm
Stallergenes Greer Booth 13
Contact Name: Suzanne Fogelman
Contact Email: suzanne.fogleman@stallergenesgreer.com
Website: www.stagrallergy.com
Takeda Booth 9
Contact Name: Aneesah Whiteside
Contact Email: aneesah.whiteside@takeda.com
Website: https://www.takeda.com/
Takeda-Pl Booth 20
Contact Name: Dodie Lockard
Contact Email: dodie.lockard@takeda.com
Website: https://www.takeda.com/
CORPORATE FORUMS (Non-CME presentations)
Inhibiting IL4 and IL13 Signaling Across AD, Asthma and EoE in Pediatrics
Supported by Sanofi & Regeneron
Food Allergy: Health Implications and Challenges
Supported by Genentech, A Member of the Roche Group
CORPORATE SUPPORTERS
DBV Technologies: Supporter of the Faculty Dinner…and the Saturday attendee lunch
Genentech, A Member of the Roche Group: Supporter of a Non-CME Corporate Forum
Nutricia North America: Supporter of a registration bag insert
Sanofi & Regeneron: Supporter of a Non-CME Corporate Forum… room keypromotion…badge lanyards…WiFi…column wraps…branded meter board…floor clings…and refreshment breaks
INDEPENDENT MEDICAL EDUCATION GRANTS
Takeda - Supporter of the Saturday Symposium on Who, When, Why and How To Start an Evaluation for Primary Immune Deficiency AND the Sunday Breakfast Symposium on How To Use Shared Decision Making To Guide Management of Eosinophilic Esophagitis.
Price
**CSACI members - use coupon code CSACI24 during checkout for discounted price**
Questions about making a payment? We use PayPal to process credit card payments, but you do not need a PayPal account to register.
Download our instructional sheet